These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 7188852)

  • 41. [A review of the effects of hormonal contraception on thyroid function (author's transl)].
    L'Hermite M; Hubinont PO
    Rev Fr Gynecol Obstet; 1976 Mar; 71(3):215-9. PubMed ID: 785576
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Association between sex hormone-binding globulin levels and activated protein C resistance in explaining the risk of thrombosis in users of oral contraceptives containing different progestogens.
    van Vliet HA; Frolich M; Christella M; Thomassen LG; Doggen CJ; Rosendaal FR; Rosing J; Helmerhorst FM
    Hum Reprod; 2005 Feb; 20(2):563-8. PubMed ID: 15539435
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Effect of hormone contraceptives, of various compositions, on insulin secretion and carbohydrate tolerance].
    Hausmann L; Groll J; Kaffarnik H
    Verh Dtsch Ges Inn Med; 1974; 80():1267-9. PubMed ID: 4454394
    [No Abstract]   [Full Text] [Related]  

  • 44. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH; Walden CE; Wahl PW; Hoover JJ; Warnick GR; Albers JJ; Ogilvie JT; Hazzard WR
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Investigation of hydroxyproline by hormonal contraception (author's transl)].
    Klinger G; Feuerstein M
    Zentralbl Gynakol; 1979; 101(5):306-8. PubMed ID: 463399
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Serum prostaglandin F levels during menstrual cycle in women using oral contraceptives.
    Garg SK
    Int J Clin Pharmacol Ther Toxicol; 1983 Aug; 21(8):431-2. PubMed ID: 6629547
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Modification of cycle-dependent changes in the uterus by the intake of hormonal contraceptives].
    Bartl W; Nasr F; Bernaschek G
    Ultraschall Med; 1984 Apr; 5(2):74-6. PubMed ID: 6729435
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The problem of modifying X-chromatin frequency using hormonal contraceptives].
    Meinhold P; Sommer K; Hoppe H; Klinger G
    Zentralbl Gynakol; 1975; 97(11):674-8. PubMed ID: 1189759
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of a desogestrel-containing oral contraceptive on glucose tolerance and leptin concentrations in hyperandrogenic women.
    Nader S; Riad-Gabriel MG; Saad MF
    J Clin Endocrinol Metab; 1997 Sep; 82(9):3074-7. PubMed ID: 9284746
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of tobacco smoking and oral contraceptive use on theophylline disposition.
    Gardner MJ; Tornatore KM; Jusko WJ; Kanarkowski R
    Br J Clin Pharmacol; 1983 Sep; 16(3):271-80. PubMed ID: 6626419
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral contraceptives and ascorbic acid.
    Rivers JM
    Am J Clin Nutr; 1975 May; 28(5):550-4. PubMed ID: 1093379
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of low-dose oral contraceptive on gonadotropins, androgens, and sex hormone binding globulin in nonhirsute women.
    Murphy A; Cropp CS; Smith BS; Burkman RT; Zacur HA
    Fertil Steril; 1990 Jan; 53(1):35-9. PubMed ID: 2136834
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of oral contraceptives on serum lipids gamma-glutamyl transpeptidase, and excretion of d-glucaric acid.
    Hajós P; Berlin I; Intödy Z; Tornyossy M; Káldor A
    Int J Clin Pharmacol Ther Toxicol; 1981 Mar; 19(3):117-23. PubMed ID: 6112206
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Evaluation of sex chromatin number in newborn infants born to mothers who have taken oral contraceptives].
    Vajda R
    Orv Hetil; 1976 Mar; 117(21):1267. PubMed ID: 1272570
    [No Abstract]   [Full Text] [Related]  

  • 55. [Histomorphology of the breast under the influence of hormonal contraceptives].
    Prechtel K; Pöschl U; Laakso K
    Arch Gynecol; 1979 Jul; 228(1-4):459-60. PubMed ID: 485439
    [No Abstract]   [Full Text] [Related]  

  • 56. Serum concentrations of ethinylestradiol, 3-keto-desogestrel, SHBG, CBG and gonadotropins during treatment with a biphasic oral contraceptive containing desogestrel.
    Jung-Hoffmann C; Storch A; Kuhl H
    Horm Res; 1992; 38(3-4):184-9. PubMed ID: 1306851
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Antithrombin and heparin-neutralizing activity in sera of women using and not using hormonal contraceptives].
    Stepanauskas M; Weissbach-Rieger A; Schwarzenecker K; Hansche N; Egger E; Heine H
    Z Med Lab Diagn; 1979; 20(5):295-301. PubMed ID: 549319
    [No Abstract]   [Full Text] [Related]  

  • 58. Antithrombin III and platelets during the normal menstrual cycle and in women receiving oral contraceptives low in oestrogen.
    Jespersen J; Ingeberg S; Bach E
    Gynecol Obstet Invest; 1983; 15(3):153-62. PubMed ID: 6832651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Histochemical and electron scanning microscopy studies of the fallopian tube under the influence of various hormones (proceedings)].
    Kugler P; Wallner HJ; Heinzmann U; Wrobel KH
    Arch Gynakol; 1977 Jul; 224(1-4):82-3. PubMed ID: 579949
    [No Abstract]   [Full Text] [Related]  

  • 60. [Could contraceptives with progestational effect cause voice changes?].
    Ned Tijdschr Geneeskd; 1975 Nov; 119(44):1726-7. PubMed ID: 1214879
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.